Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 7.0 Contact Hours.
This activity is supported by educational grants from Array BioPharma Inc., Incyte, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Prometheus Laboratories Inc., and Reata Pharmaceuticals.
February 11, 2017
Trump International Miami
18001 Collins Avenue
Sunny Isles Beach, FL 33160
The 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational and scientific meeting that will focus on contemporary approaches in the management of melanoma and other cutaneous malignancies, as well as future directions in therapy.
The field of skin cancer treatment has been at the forefront in oncology in recent times, and has been a major focus of novel drug development. In particular, the advent of targeted and immunotherapeutic approaches to manage these malignancies has transformed care, in recent years. There are also many investigational strategies in late-stage development, and these promise to further change practice in 2017. This is great news for patients, but also challenges busy clinicians to maintain state-of-the-art approaches in their practices.
This year’s program, led by world-class experts Omid Hamid, MD and Jeffrey Weber, MD, PhD, will focus on a number of core areas that are key to personalizing care for these tumors in contemporary practices settings, including sessions on immunotherapies, targeted therapies, regional therapy, predictive/prognostic modeling, and integrated medicine/patient care. This fast-paced, highly practical, and interactive forum will once again provide physicians who treat patients with skin cancer unique access to renowned international experts in the management of these tumors.
This educational activity is directed toward medical oncologists, fellows, surgical oncologists, and radiation oncologists who treat patients with skin and other cutaneous malignancies. Dermatologists, dermatopathologists and pathologists, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of melanoma and other cutaneous malignancies will be invited to participate.
At the conclusion of this symposium, you should be better prepared to:
- Choose treatment based on patient characteristics, such as age and performance status.
- Assess the roles of regional therapies, targeted therapies, and immunotherapies in the treatment of patients.
- Review strategies for mitigating and managing adverse events related to therapy.
- Describe current and emerging strategies for individualizing therapy.
- Evaluate emerging clinical data regarding new regional therapies, targeted therapies, and immunotherapies in treating melanoma and other cutaneous malignancies.
Jeffrey Weber, MD, PhD
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU Langone Medical Center
New York, NY
Omid Hamid, MD
Chief, Translational Research & Immuno-Oncology
Director, Cutaneous Malignancies – The Angeles Clinic and Research Institute
Director of Experimental Therapeutics, Cedars Sinai Medical Care Foundation
Los Angeles, CA
Feb 28, 2017
Cancer Summaries and Commentaries™: Updates from Singapore: Advances in Personalized Lung Cancer Treatment
Feb 28, 2017